Advertisement
Person › Details
Pilar de la Huerta Martinez (Sygnis Pharma AG)
de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)
Organisation | Sygnis Pharma AG | |
Today | Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) | |
Group | 2invest (Group) | |
Former/major organisation | Genetrix S.L. | |
Today | Expedeon Biotech S.L.U. | |
Group | 2invest (Group) | |
Product | BIOTECH | |
Product 2 | Qualiphi® DNA polymerase | |
Record changed: 2024-07-17 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top